Published in Genes Dev on July 15, 1997
Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev (2001) 3.41
CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol (1999) 2.84
Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol (2007) 2.66
Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol (1998) 2.10
PUMA- and Bax-induced autophagy contributes to apoptosis. Cell Death Differ (2009) 1.83
Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. J Clin Invest (2010) 1.74
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc Natl Acad Sci U S A (1999) 1.67
Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo. PLoS Genet (2006) 1.66
Telencephalon-specific Rb knockouts reveal enhanced neurogenesis, survival and abnormal cortical development. EMBO J (2002) 1.62
Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol Cell Biol (1998) 1.51
E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas. Mol Cell Biol (2003) 1.50
Gene expression changes in response to E2F1 activation. Nucleic Acids Res (2002) 1.44
E2F-1 represses transcription of the human telomerase reverse transcriptase gene. Nucleic Acids Res (2001) 1.35
Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J (1999) 1.30
mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53. Mol Cell Biol (2002) 1.28
Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol (2003) 1.27
The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell (2008) 1.21
Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol Cell Biol (2000) 1.18
Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Mol Cell Biol (2002) 1.13
Induction of p57(KIP2) expression by p73beta. Proc Natl Acad Sci U S A (2002) 1.11
Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. J Clin Pathol (1999) 1.08
ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol (2002) 1.07
Apoptotic and growth-promoting activity of E2F modulated by MDM2. Mol Cell Biol (2000) 1.06
Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div (2009) 1.02
Transcriptional repression of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1. J Biol Chem (2008) 1.02
Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors. Mol Cell Biol (1998) 1.01
DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis. J Zhejiang Univ Sci B (2007) 0.99
Inhibition of cyclin-dependent kinase activity and induction of apoptosis by preussin in human tumor cells. Antimicrob Agents Chemother (2000) 0.98
Deregulated E2F transcriptional activity in autonomously growing melanoma cells. J Exp Med (2000) 0.97
E2F1 death pathways as targets for cancer therapy. J Cell Mol Med (2007) 0.97
Regulation of E2F1-induced apoptosis by the nucleolar protein RRP1B. J Biol Chem (2009) 0.94
Induction of DNA synthesis and apoptosis by regulated inactivation of a temperature-sensitive retinoblastoma protein. EMBO J (1998) 0.94
Regulation of E2F1 by APC/C Cdh1 via K11 linkage-specific ubiquitin chain formation. Cell Cycle (2012) 0.93
Regulation of E2F1-dependent gene transcription and apoptosis by the ETS-related transcription factor GABPgamma1. Mol Cell Biol (2002) 0.93
Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes. J Virol (2002) 0.92
Induction of the cellular E2F-1 promoter by the adenovirus E4-6/7 protein. J Virol (2000) 0.91
Disruption of retinoblastoma protein family function by human papillomavirus type 16 E7 oncoprotein inhibits lens development in part through E2F-1. Mol Cell Biol (1999) 0.87
S phase-coupled E2f1 destruction ensures homeostasis in proliferating tissues. PLoS Genet (2012) 0.87
Alcohol exposure alters cell cycle and apoptotic events during early neurulation. Alcohol Alcohol (2008) 0.87
Eye cancer: unique insights into oncogenesis: the Cogan Lecture. Invest Ophthalmol Vis Sci (2006) 0.86
E2F2 and CREB cooperatively regulate transcriptional activity of cell cycle genes. Nucleic Acids Res (2013) 0.85
Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells. J Virol (2001) 0.85
A transcriptionally active pRb-E2F1-P/CAF signaling pathway is central to TGFβ-mediated apoptosis. Cell Death Dis (2012) 0.85
E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression. Cell Cycle (2008) 0.80
Efficient virotherapy for osteosarcoma by telomerase-specific oncolytic adenovirus. J Cancer Res Clin Oncol (2010) 0.80
Deregulation of the p57-E2F1-p53 axis results in nonobstructive hydrocephalus and cerebellar malformation in mice. Mol Cell Biol (2011) 0.78
Cleavage of E2F-1-regulating proteins and activation of E2F-1 during CD95-induced death of thymocytes. Immunology (2001) 0.75
Regulation of p53 stability by Mdm2. Nature (1997) 18.20
Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore (1994) 16.38
PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell (2001) 11.04
Proliferation, cell cycle and apoptosis in cancer. Nature (2001) 9.57
Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J Biol Chem (2000) 6.92
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J (1989) 6.60
E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev (2001) 6.13
The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J (1998) 6.08
Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet (2000) 5.50
p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78
Trends in medical use and abuse of opioid analgesics. JAMA (2000) 4.23
E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene. J Virol (1986) 4.04
Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet (1992) 3.85
Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature (2000) 3.83
The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75
Role of NF-kappaB in p53-mediated programmed cell death. Nature (2000) 3.62
Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell (1991) 3.58
Coping with stress: multiple ways to activate p53. Oncogene (2007) 3.57
Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol (2001) 3.46
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev (1995) 3.40
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.25
Regulation of p53 function and stability by phosphorylation. Mol Cell Biol (1999) 3.24
Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature (1997) 3.16
Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol (2000) 3.12
Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J (1999) 3.05
A population of fast radio bursts at cosmological distances. Science (2013) 3.03
Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev (1997) 3.02
A point mutational analysis of human papillomavirus type 16 E7 protein. J Virol (1989) 3.00
Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol (2001) 2.96
CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol (1999) 2.84
p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene (1991) 2.76
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet (2000) 2.69
Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes Dev (2000) 2.58
The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J (1990) 2.57
Regulation of p53 stability. Oncogene (1999) 2.54
Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci U S A (1995) 2.48
Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J (1992) 2.45
Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol (1996) 2.44
The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta (2000) 2.34
Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol Cell Biol (1997) 2.27
p53 in signaling checkpoint arrest or apoptosis. Curr Opin Genet Dev (1996) 2.26
Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J (1995) 2.26
Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene (1993) 2.20
Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for the spindle checkpoint. EMBO J (2001) 2.13
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J (1996) 2.12
E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene (1998) 2.12
C-terminal ubiquitination of p53 contributes to nuclear export. Mol Cell Biol (2001) 2.09
Cell cycle-regulated expression of mammalian CDC6 is dependent on E2F. Mol Cell Biol (1998) 2.07
Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell (1994) 2.06
Identification of a cryptic nucleolar-localization signal in MDM2. Nat Cell Biol (2000) 2.02
Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol Cell Biol (1996) 1.99
Retracted Relation between infection with a subtype of HPV16 and cervical neoplasia. Lancet (1989) 1.94
p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J (1991) 1.91
Activation and activities of the p53 tumour suppressor protein. Br J Cancer (2001) 1.90
A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene (2000) 1.85
PUMA- and Bax-induced autophagy contributes to apoptosis. Cell Death Differ (2009) 1.83
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1. J Virol (1993) 1.78
E2F family members are differentially regulated by reversible acetylation. J Biol Chem (2000) 1.77
Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene (1990) 1.76
Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol Cell Biol (1993) 1.75
Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol (1997) 1.73
Regulation of Mdm2-directed degradation by the C terminus of p53. Mol Cell Biol (1998) 1.69
The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol Cell Biol (1998) 1.69
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA (1998) 1.67
Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion. Oncogene (2012) 1.62
Mdm2 binds p73 alpha without targeting degradation. Oncogene (1999) 1.62
Mechanisms of p53-mediated apoptosis. Cell Mol Life Sci (1999) 1.62
Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene (2008) 1.60
Two individuals with elliptocytic red cells apparently lack three minor erythrocyte membrane sialoglycoproteins. Biochem J (1984) 1.56
Regulation of p53 function. Exp Cell Res (2001) 1.55
Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. J Clin Endocrinol Metab (2001) 1.54
Life and death decisions by E2F-1. Cell Death Differ (2004) 1.50
Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol Cell Biol (1998) 1.50
Analysis of the degradation function of Mdm2. Cell Growth Differ (1999) 1.49
Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression. Oncogene (1998) 1.41
Intraoperative mannitol does not prevent renal failure in orthotopic liver transplantation. Crit Care Resusc (2001) 1.40
Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide. Nature (1984) 1.40
New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene (2012) 1.40
Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J (1992) 1.39
p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death. Cell Death Differ (2007) 1.39
Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene (1996) 1.39
p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol Cell Biol (1997) 1.37
Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene (1995) 1.34
E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell (1999) 1.34
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol (1993) 1.34
Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Mol Carcinog (1991) 1.33
Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells. Biochem Biophys Res Commun (2001) 1.33
Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation. Oncogene (1994) 1.32